Insiders · TLX

TLX insider transactions

Telix Pharmaceuticals Limited (TLX) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

TLX insiders

Everyone who has filed a Form 3, 4, 5 or 144 at Telix Pharmaceuticals Limited, latest first. Follow anyone to get their next filing.

• Darren Charlton SmithGroup Chief Financial Officer, since March 2026+$20K
• David N GillDirector, since May 2026
• William R JellisonDirector, since May 2026
• Maria RivasDirector, since May 2026
• Christian BehrenbruchMD & Group CEO, Director, since March 2026+$997K
• David Norman CadeGroup Chief Medical Officer, since March 2026
• Mark Alexander NelsonDirector, since March 2026
• Darren Joel PattiGroup Chief Operating Officer, since March 2026
• Marie Elizabeth McDonaldDirector, since March 2026
• Jann Elizabeth SkinnerDirector, since March 2026

Recent Form 3, 4, and 5 filings for TLX

• 55d
  Group Chief Financial Officer Smith Darren Charlton bought $19,998 worth of Ordinary Shares (2,071 units at $9.66), increasing direct ownership by 17% to 13,992 units (SEC Form 4)

  4 - Telix Pharmaceuticals Ltd (0002007191) (Issuer)
• 174d
  SEC Form 3 filed by new insider Gill David N

  3 - Telix Pharmaceuticals Ltd (0002007191) (Issuer)
• 174d
  SEC Form 3 filed by new insider Jellison William R

  3 - Telix Pharmaceuticals Ltd (0002007191) (Issuer)
• 174d
  SEC Form 3 filed by new insider Rivas Maria

  3 - Telix Pharmaceuticals Ltd (0002007191) (Issuer)
• 186d
  MD & Group CEO Behrenbruch Christian bought $996,738 worth of Ordinary Shares (67,935 units at $14.67) (SEC Form 4)

  4 - Telix Pharmaceuticals Ltd (0002007191) (Issuer)
• 221d
  SEC Form 4 filed by Smith Darren Charlton

  4 - Telix Pharmaceuticals Ltd (0002007191) (Issuer)
• 222d
  SEC Form 3 filed by new insider Cade David Norman

  3 - Telix Pharmaceuticals Ltd (0002007191) (Issuer)
• 222d
  SEC Form 3 filed by new insider Smith Darren Charlton

  3 - Telix Pharmaceuticals Ltd (0002007191) (Issuer)
• 222d
  SEC Form 3 filed by new insider Nelson Mark Alexander

  3 - Telix Pharmaceuticals Ltd (0002007191) (Issuer)
• 222d
  SEC Form 3 filed by new insider Patti Darren Joel

  3 - Telix Pharmaceuticals Ltd (0002007191) (Issuer)
• 235d
  SEC Form 3 filed by new insider Mcdonald Marie Elizabeth

  3 - Telix Pharmaceuticals Ltd (0002007191) (Issuer)
• 235d
  SEC Form 3 filed by new insider Skinner Jann Elizabeth

  3 - Telix Pharmaceuticals Ltd (0002007191) (Issuer)
• 235d
  SEC Form 3 filed by new insider Behrenbruch Christian

  3 - Telix Pharmaceuticals Ltd (0002007191) (Issuer)